Quick Answer
Can-Fite BioPharma Ltd. reported Total Revenue of $405.0 thousand for fiscal year 2025.
Can-Fite BioPharma Ltd. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $405.0K | -39.9% |
| 2024 | $674.0K | -9.3% |
| 2023 | $743.0K | -8.3% |
| 2022 | $810.0K | -5.0% |
| 2021 | $853.0K | +11.8% |
| 2020 | $763.0K | -62.5% |
| 2019 | $2.03M | -46.8% |
| 2018 | $3.82M | — |
- Can-Fite BioPharma Ltd. showed a decrease of -39.9% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, Can-Fite BioPharma Ltd.’s total revenue has declined by 89.4% (from $3.82 million to $405.0 thousand).
- The most recent figure is from Can-Fite BioPharma Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: